Company KPI Data Charting Tools Stock Screener Industry Financials Time Series Tables

Login Start for Free

My Subscriptions My Account My Orders Log Out

Research Tools

Company KPI Data
Charting Tools
Stock Screener
Industry Financials
Time Series Tables

Login Start for Free

Overview
Financial Statements
KPIs & Operating Metrics
Peers
Ownership
- Institutional Ownership
- Insider Ownership
SEC Filings
Charts

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Beginning Cash Balance Change in Account Payables Change in Accured Expenses Change in Receivables Change in Taxes Current Debt Gains from Sales and Divestitures Net Debt Issuances and Repayments Non-cash Items Other Working Capital Changes

Daily Values

DMA 100 DMA 200 DMA 50 Dividend Yield EV to CFO EV to EBIT EV to EBITDA EV to FCF EV to Revenue Market Cap to FCF Price Price to Book Price to Earnings Price to Sales

Growth Metrics

Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)

Income Statement

EPS (Weighted Average and Diluted)Operating Expenses Restructuring Costs Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)

Others

Accumulated Depreciation & Amortization Leases Loans and Notes Receivables Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Shares Outstanding Short-Term Debt repayments

Ratios

Assets Average Debt Ratio Debt to Equity Enterprise Value Equity Average Equity Ratio Inventory Average Invested Capital Market Capitalization

China SXT Pharmaceuticals (SXTC) Cash & Equivalents Growth (5y): 2023-2025

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Peer Comparison

Historic Data

Download Data 🔒

Date	Value

×

Your powerful stock research platform

Resources

About Us
Sitemap
Contact Us

Company

Terms of Use
Privacy Policy
Plans & Pricing
Schedule a Demo

Create an account

Start your journey with us today. It's free!

I agree to the privacy policy.

Have an account already? Sign In

Sign In

Welcome back! Please enter your details.

Remember Me

Forgot Password?

Don't have an account? Create one now

Reset Password

Enter your email to receive a reset link.

Back to Sign In

Get Pro for 60% off

Access all features immediately
Segment financials and operating data
Export data in CSV and XLSX formats

Offer Ends In

00Days

00Hours

00Minutes

00Seconds

Starting from ~~$49~~ $19 / month

Claim Discount